BettsGDHynesTJWinstanleyCA (2021) Pharmacological evidence of a cholinergic contribution to elevated impulsivity and risky decision-making caused by adding win-paired cues to a rat gambling task. J Psychopharmacol. Epub ahead of print 11 February 2021. DOI: 10.1177/0269881120972421.
ChiappiniSSchifanoFCorkeryJM, et al. (2021) Beyond the ‘purple drank’: Study of promethazine abuse according to the European Medicines Agency adverse drug reaction reports. J Psychopharmacol. Epub ahead of print 10 January 2021. DOI: 10.1177/0269881120959615.
4.
FeldGBBergmannTOAlizadeh-AsfestaniM, et al. (2021) Specific changes in sleep oscillations after blocking human metabotropic glutamate receptor 5 in the absence of altered memory function. J Psychopharmacol. Epub ahead of print 25 April 2021. DOI: 10.1177/02698811211005627.
5.
FinebergNAHaddadPMCarpenterL, et al. (2013) The size, burden and cost of disorders of the brain in the UK. J Psychopharmacol27: 761–770. DOI: 10.1177/0269881113495118.
6.
LinZLiuCFanE, et al. (2021) An efficient and label-free LC-MS/MS method for assessing drug’s activity at dopamine and serotonin transporters using transporter-transfected HEK293T cells. J Psychopharmacol. Epub ahead of print 22 April 2021. DOI: 10.1177/02698811211008576.
7.
LivermoreJJHolmesCLCutlerJ, et al. (2021) Selective effects of serotonin on choices to gather more information. J Psychopharmacol. Epub ahead of print 18 February 2021. DOI: 10.1177/0269881121991571.
8.
Looti BashiyanMNasehiMVaseghiS, et al. (2021) Investigating the effect of crocin on memory deficits induced by total sleep deprivation (TSD) with respect to the BDNF, TrkB and ERK levels in the hippocampus of male Wistar rats. J Psychopharmacol. Epub ahead of print 25 April 2021. DOI: 10.1177/02698811211000762.
9.
MetzSChaeWRDeuterCE, et al. (2021) Effects of hydrocortisone and yohimbine on selective attention to emotional cues. J Psychopharmacol. Epub ahead of print 28 March 2021. DOI: 10.1177/0269881121997100.
10.
NirogiRGrandhiVRMedapatiRB, et al. (2021) Histamine 3 receptor inverse agonist Samelisant (SUVN-G3031): Pharmacological characterization of an investigational agent for the treatment of cognitive disorders. J Psychopharmacol. Epub ahead of print 5 February 2021. DOI: 10.1177/0269881120986418.
11.
Peled-AvronLGelbard GorenHBrande-EilatN, et al. (2021) Methylphenidate reduces orienting bias in healthy individuals. J Psychopharmacol. Epub ahead of print 15 March 2021. DOI: 10.1177/0269881121996884.
12.
Steudte-SchmiedgenSFayECapitaoL, et al. (2021) Hydrocortisone as an adjunct to brief cognitive-behavioural therapy for specific fear: Endocrine and cognitive biomarkers as predictors of symptom improvement. J Psychopharmacol. Epub ahead of print 28 April 2021. DOI: 10.1177/02698811211001087.
13.
TanqueiroSMouroFFerreiraC, et al. (2021) Sustained NMDA receptor hypofunction impairs brain-derived neurotropic factor (BDNF) signalling in the prefrontal cortex (PFC), but not in the hippocampus, and disturbs PFC-dependent cognition in mice. J Psychopharmacol. (in press).
14.
ThomasEMFreemanTPPoplutzP, et al. (2021) Stimulating meditation: A pre-registered randomised controlled experiment combining a single dose of the cognitive enhancer, modafinil, with brief mindfulness training. J Psychopharmacol. Epub ahead of print 1 March 2021. DOI: 10.1177/0269881121991835.
15.
YoungAH (2004) Cortisol in mood disorders. Stress7: 205–208. DOI: 10.1080/10253890500069189.
16.
ZhengXXuXXuL, et al. (2021) Intranasal oxytocin may help maintain romantic bonds by decreasing jealousy evoked by either imagined or real partner infidelity. J Psychopharmacol. Epub ahead of print 18 February 2021. DOI: 10.1177/0269881121991576.